Emerging Insights Into the Pathophysiology of Multisystem Inflammatory Syndrome Associated With COVID-19 in Children

[1]  Young Tae Lim,et al.  Kawasaki disease following SARS-CoV-2 infection: Stronger inflammation with no increase in cardiac complications , 2022, Frontiers in Pediatrics.

[2]  H. Cohen,et al.  A machine-learning algorithm for diagnosis of multisystem inflammatory syndrome in children and Kawasaki disease in the USA: a retrospective model development and validation study , 2022, The Lancet. Digital health.

[3]  J. Bost,et al.  Examining the Association Between MIS-C and the Child Opportunity Index at a Single Center. , 2022, Hospital pediatrics.

[4]  A. Randolph,et al.  BNT162b2 mRNA Vaccination Against COVID-19 is Associated with Decreased Likelihood of Multisystem Inflammatory Syndrome in U.S. Children Ages 5–18 Years , 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  M. Portman,et al.  Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease , 2022, JAMA network open.

[6]  J. Burney,et al.  Epidemiological and Clinical Features of Kawasaki Disease During the COVID-19 Pandemic in the United States , 2022, JAMA network open.

[7]  D. Sahoo,et al.  An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease , 2022, Nature Communications.

[8]  H. Kim,et al.  Changes in the Clinical Characteristics of Kawasaki Disease After Coronavirus Disease (COVID-19) Pandemic: A Database Analysis , 2022, Journal of Korean medical science.

[9]  P. Monagle,et al.  Pathophysiological pathway differences in children who present with COVID-19 ARDS compared to COVID -19 induced MIS-C , 2022, Nature Communications.

[10]  A. Alsheikh-Ali,et al.  Genetic and Clinical Characteristics of Patients in the Middle East With Multisystem Inflammatory Syndrome in Children , 2022, JAMA network open.

[11]  L. S. Schmidt,et al.  Incidence and clinical phenotype of multisystem inflammatory syndrome in children after infection with the SARS-CoV-2 delta variant by vaccination status: a Danish nationwide prospective cohort study , 2022, The Lancet Child & Adolescent Health.

[12]  A. Pariente,et al.  Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study , 2022, The Lancet Regional Health - Europe.

[13]  J. Karakaya,et al.  The difference of the inflammatory milieu in MIS-C and severe COVID-19 , 2022, Pediatric Research.

[14]  K. Roemer,et al.  Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study , 2022, The Lancet Rheumatology.

[15]  R. Cron,et al.  Hemophagocytic Lymphohistiocytosis Gene Variants in Multisystem Inflammatory Syndrome in Children , 2022, Biology.

[16]  M. Askenazi,et al.  Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19 , 2022, Nature Medicine.

[17]  M. Oster,et al.  Cardiac Magnetic Resonance Findings After Multisystem Inflammatory Syndrome in Children. , 2022, The Journal of pediatrics.

[18]  Allan W. Taylor,et al.  Reported cases of multisystem inflammatory syndrome in children aged 12–20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation , 2022, The Lancet Child & Adolescent Health.

[19]  E. Javouhey,et al.  Multisystem Inflammatory Syndrome in Children by COVID-19 Vaccination Status of Adolescents in France. , 2021, JAMA.

[20]  Y. Saeys,et al.  TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C , 2021, The Journal of experimental medicine.

[21]  B. McCrindle,et al.  Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults: Suspected Myocarditis After COVID-19 Vaccination , 2021, Circulation.

[22]  G. Di Salvo,et al.  Myocardial involvement in children with post-COVID multisystem inflammatory syndrome: a cardiovascular magnetic resonance based multicenter international study—the CARDOVID registry , 2021, Journal of Cardiovascular Magnetic Resonance.

[23]  A. Moreira,et al.  Multisystem inflammatory syndrome (MIS-C): a systematic review and meta-analysis of clinical characteristics, treatment, and outcomes , 2021, Jornal de pediatria.

[24]  E. Wherry,et al.  Proteomic profiling of MIS-C patients indicates heterogeneity relating to interferon gamma dysregulation and vascular endothelial dysfunction , 2021, Nature Communications.

[25]  M. Salvadori,et al.  Multisystem inflammatory syndrome in children in Canada. , 2021, Canada communicable disease report = Releve des maladies transmissibles au Canada.

[26]  D. Singh-Grewal,et al.  Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison , 2021, Nature Reviews Rheumatology.

[27]  L. Vella,et al.  Current Insights Into the Pathophysiology of Multisystem Inflammatory Syndrome in Children , 2021, Current Pediatrics Reports.

[28]  Sophie Rhys-Evans.  Call for a universal PIMS-TS/MIS-C case definition , 2021, Archives of Disease in Childhood.

[29]  E. Wu,et al.  Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Following COVID-19 , 2021, Current Cardiology Reports.

[30]  G. Alter,et al.  The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in children. , 2021, The Journal of clinical investigation.

[31]  Benjamin S. Glicksberg,et al.  Downregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children , 2021, Nature Communications.

[32]  M. Oster,et al.  Racial and Ethnic Disparities in Multisystem Inflammatory Syndrome in Children in the United States, March 2020 to February 2021 , 2021, The Pediatric infectious disease journal.

[33]  Evida A Dennis-Heyward.  Disparities in Susceptibility to Multisystem Inflammatory Syndrome in Children. , 2021, JAMA pediatrics.

[34]  H. Bukulmez.  Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease , 2021, Current Rheumatology Reports.

[35]  David A. Williams,et al.  Mechanisms underlying genetic susceptibility to multisystem inflammatory syndrome in children (MIS-C) , 2021, Journal of Allergy and Clinical Immunology.

[36]  G. Schulert,et al.  Inflammatory biomarkers in COVID-19-associated multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activation syndrome: a cohort study , 2021, The Lancet Rheumatology.

[37]  Dong Wook Kim,et al.  Reduction in Kawasaki Disease After Nonpharmaceutical Interventions in the COVID-19 Era , 2021, Circulation.

[38]  Manish M Patel,et al.  Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2 , 2021, JAMA network open.

[39]  J. Casanova,et al.  Polyclonal expansion of TCR Vbeta 21.3+ CD4+ and CD8+ T cells is a hallmark of Multisystem Inflammatory Syndrome in Children , 2021, Science Immunology.

[40]  Mark S. Anderson,et al.  SARS-CoV-2–related MIS-C: A key to the viral and genetic causes of Kawasaki disease? , 2021, The Journal of experimental medicine.

[41]  A. Delgado,et al.  An autopsy study of the spectrum of severe COVID-19 in children: From SARS to different phenotypes of MIS-C , 2021, EClinicalMedicine.

[42]  D. Hafler,et al.  Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children , 2021, Immunity.

[43]  M. Tobin-D'Angelo,et al.  Trends in Geographic and Temporal Distribution of US Children With Multisystem Inflammatory Syndrome During the COVID-19 Pandemic. , 2021, JAMA pediatrics.

[44]  M. Chiarini,et al.  Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-γ Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome , 2021, Frontiers in Immunology.

[45]  Lei Tang,et al.  The inflammatory markers of multisystem inflammatory syndrome in children (MIS‐C) and adolescents associated with COVID‐19: A meta‐analysis , 2021, Journal of medical virology.

[46]  M. H. Cheng,et al.  HLA class I-associated expansion of TRBV11-2 T cells in Multisystem Inflammatory Syndrome in Children. , 2021, The Journal of clinical investigation.

[47]  M. Oster,et al.  Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study , 2021, The Lancet Child & Adolescent Health.

[48]  Manish M Patel,et al.  Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. , 2021, JAMA.

[49]  Jeffrey I. Campbell,et al.  Socioeconomic and Racial and/or Ethnic Disparities in Multisystem Inflammatory Syndrome , 2021, Pediatrics.

[50]  E. Amirian,et al.  Multisystem inflammatory syndrome in children (MIS-C) and the coronavirus pandemic: Current knowledge and implications for public health , 2021, Journal of Infection and Public Health.

[51]  L. Henderson,et al.  MIS-C: early lessons from immune profiling , 2020, Nature Reviews Rheumatology.

[52]  M. Cunningham,et al.  Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis—A Critical Review of Its Pathogenesis and Treatment , 2020, Frontiers in Pediatrics.

[53]  T. Kuno,et al.  COVID‐19 and multisystem inflammatory syndrome in children: A systematic review and meta‐analysis , 2020, Pediatric pulmonology.

[54]  T. Cassidy-Smith,et al.  Multisystem Inflammatory Syndrome in Children , 2020, The Journal of Emergency Medicine.

[55]  M. H. Cheng,et al.  Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation , 2020, Proceedings of the National Academy of Sciences.

[56]  E. Wherry,et al.  Deep Immune Profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19 , 2020, medRxiv.

[57]  K. Wilson,et al.  Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C) , 2020, Cell.

[58]  Douglas R. McDonald,et al.  Immune dysregulation and multisystem inflammatory syndrome in children (MIS-C) in individuals with haploinsufficiency of SOCS1 , 2020, Journal of Allergy and Clinical Immunology.

[59]  J. R. Rebello Pinho,et al.  SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome , 2020, The Lancet Child & Adolescent Health.

[60]  J. Newburger,et al.  Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children. , 2020, Circulation.

[61]  F. Haerynck,et al.  Multisystem inflammatory syndrome in children related to COVID-19: a systematic review , 2020, European Journal of Pediatrics.

[62]  M. Malim,et al.  Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection , 2020, Nature Medicine.

[63]  P. Agrawal,et al.  Multi-system inflammatory syndrome in children & adolescents (MIS-C): A systematic review of clinical features and presentation , 2021 .

[64]  E. Chow,et al.  Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2: A Systematic Review , 2020, The Journal of Pediatrics.

[65]  K. Sullivan,et al.  Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2. , 2020, The Journal of clinical investigation.

[66]  P. Palma,et al.  The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19 , 2020, Cell.

[67]  K. Wilson,et al.  Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C) , 2020, medRxiv.

[68]  Lanjuan Li,et al.  Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study , 2020, The Journal of infectious diseases.

[69]  S. Lakshminrusimha,et al.  Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management , 2020, Children.

[70]  David R. Holtgrave,et al.  Multisystem Inflammatory Syndrome in Children in New York State , 2020, The New England journal of medicine.

[71]  Simon Li,et al.  Multisystem Inflammatory Syndrome in U.S. Children and Adolescents , 2020, The New England journal of medicine.

[72]  S. Klein,et al.  Considering how biological sex impacts immune responses and COVID-19 outcomes , 2020, Nature Reviews Immunology.

[73]  B. McCrindle,et al.  SARS-CoV-2-Related Inflammatory Multisystem Syndrome in Children: Different or Shared Etiology and Pathophysiology as Kawasaki Disease? , 2020, JAMA.

[74]  Supinda Bunyavanich,et al.  Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults. , 2020, JAMA.

[75]  Y. Prakash,et al.  Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells , 2020, American journal of physiology. Lung cellular and molecular physiology.

[76]  L. Bonnemains,et al.  Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic , 2020, Circulation.

[77]  Angelo Mazza,et al.  An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study , 2020, The Lancet.

[78]  R. Ureshino,et al.  SARS‐CoV‐2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[79]  P. Theocharis,et al.  Hyperinflammatory shock in children during COVID-19 pandemic , 2020, The Lancet.

[80]  J. Ludvigsson.  Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults , 2020, Acta paediatrica.

[81]  James M. Eales,et al.  The Y chromosome: a blueprint for men’s health? , 2017, European Journal of Human Genetics.

[82]  B. McCrindle,et al.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association , 2017, Circulation.

[83]  S. Klein,et al.  Progesterone-based compounds affect immune responses and susceptibility to infections at diverse mucosal sites , 2017, Mucosal Immunology.

[84]  Mark M. Davis,et al.  Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination , 2013, Proceedings of the National Academy of Sciences.

[85]  J. Zachary,et al.  The Y chromosome as a regulatory element shaping immune cell transcriptomes and susceptibility to autoimmune disease , 2013, Genome research.

[86]  R. Straub,et al.  The complex role of estrogens in inflammation. , 2007, Endocrine reviews.

[87]  E. Shapiro,et al.  Association between a Novel Human Coronavirus and Kawasaki Disease , 2005, The Journal of infectious diseases.

[88]  Ba,et al.  Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults , 2020 .

[89]  R. Corrin,et al.  Canada Communicable Disease Report Relevé des maladies transmissibles au Canada , 2005 .